Cargando…
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review
Coronavirus disease 2019 (COVID-19) changed healthcare across the world. With this change came an increase in healthcare-associated infections (HAIs) and a concerning concurrent proliferation of MDR organisms (MDROs). In this narrative review, we describe the impact of COVID-19 on HAIs and MDROs, de...
Autores principales: | Witt, Lucy S, Howard-Anderson, Jessica R, Jacob, Jesse T, Gottlieb, Lindsey B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798082/ https://www.ncbi.nlm.nih.gov/pubmed/36601548 http://dx.doi.org/10.1093/jacamr/dlac130 |
Ejemplares similares
-
Use of contact precautions for multidrug-resistant organisms and the impact of the COVID-19 pandemic: An Emerging Infections Network (EIN) survey
por: Howard-Anderson, Jessica, et al.
Publicado: (2023) -
Impact of exposure to potentially contaminated hospital beds on risk of hospital-onset C. difficile infection
por: Witt, Lucy, et al.
Publicado: (2022) -
The impact of the COVID-19 pandemic on healthcare acquired infections with multidrug resistant organisms
por: Cole, Jennifer, et al.
Publicado: (2021) -
328 Clinical Impact of Multidrug-Resistant Organisms (MDRO) causing Healthcare-Associated Infections (HAIs) in 10 Colombian cities
por: Motoa, Gabriel, et al.
Publicado: (2014) -
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
por: Lee, Nan-Yao, et al.
Publicado: (2019)